机会性致病真菌解脂耶氏酵母研究进展

摘要/Abstract

摘要： 解脂耶氏酵母（Yarrowia lipolytica）是非常规酵母中最具代表性的一种二型性酵母，在现代生物医学和生物技术领域有着广泛的应用前景。然而，近年来不断有散发病例和医院感染的报道，尤其是可引起留置中心静脉导管的免疫缺陷或危重患者发生化脓性血栓静脉炎和真菌血症。本文旨在从病原真菌的角度出发，阐述解脂耶氏酵母流行病学、毒力因子、体外抗真菌药物敏感性以及临床诊疗的国内外研究进展。

关键词: 解脂耶氏酵母, 血管导管相关感染, 流行病学, 致病力, 抗真菌药物敏感性试验, 诊疗

中图分类号:

R379.9

郁谨菡, 赵颖, 徐英春. 机会性致病真菌解脂耶氏酵母研究进展[J]. 中国真菌学杂志, 2022, 17(2): 168-172.

参考文献

[1] BARTH G, GAILLARDIN C. Physiology and genetics of the dimorphic fungus Yarrowia lipolytica[J]. FEMS Microbiol Rev, 1997, 19(4):219-237.
[2] BILAL M, XU S, IQBAL H M N, et al. Yarrowia lipolytica as an emerging biotechnological chassis for functional sugars biosynthesis[J]. Crit Rev Food Sci Nutr, 2021, 61(4):535-552.
[3] SUN T, YU Y, WANG K, et al. Engineering Yarrowia lipolytica to produce fuels and chemicals from xylose:A review[J]. Bioresour Technol, 2021, 337:125484.DOI:10.1016/j.biortech.2021.125484.
[4] GROENEWALD M, BOEKHOUT T, NEUVEGLISE C, et al. Yarrowia lipolytica:safety assessment of an oleaginous yeast with a great industrial potential[J]. Crit Rev Microbiol, 2014, 40(3):187-206.
[5] BAHLOUL M, CHTARA K, TURKI O, et al. Yarrowia lipolytica fungemia in patients with severe polytrauma requiring intensive care admission:analysis of 32 cases[J]. Intensive Care Med, 2017, 43(12):1921-1923.
[6] TRABELSI H, CHTARA K, KHEMAKHEM N, et al. Fungemia caused by Yarrowia lipolytica[J]. Mycopathologia, 2015, 179(5-6):437-445.
[7] ZHAO Y, CHAN J F, TSANG C C, et al. Clinical characteristics, laboratory identification, and in vitro antifungal susceptibility of Yarrowia (Candida) lipolytica isolates causing fungemia:a multicenter, prospective surveillance study[J]. J Clin Microbiol, 2015, 53(11):3639-3645.
[8] DESNOS-OLLIVIER M, LETSCHER-BRU V, NEUVEGLISE C, et al. Yarrowia lipolytica causes sporadic cases and local outbreaks of infections and colonisation[J]. Mycoses, 2020, 63(7):737-745.
[9] IRBY R F, KANDULA M, ZADIKANY R, et al. Yarrowia lipolytica as normal human flora[J]. Infect Dis Clin Pract, 2014, 22(4):207-209.
[10] GOUBA N, DRANCOURT M. Digestive tract mycobiota:a source of infection[J]. Med Mal Infect, 2015, 45(1-2):9-16.
[11] XIAO M, SUN Z Y, KANG M, et al. Five-year national surveillance of invasive candidiasis:species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study[J]. J Clin Microbiol, 2018, 56(7):e00577-18.
[12] PFALLER M A, DIEKEMA D J, TURNIDGE J D, et al. Twenty years of the SENTRY antifungal surveillance program:Results for species from 1997-2016[J]. Open forum infectious diseases, 2019, 6(Suppl 1):S79-S94.
[13] BRETAGNE S, RENAUDAT C, DESNOS-OLLIVIER M, et al. Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14)[J]. J Antimicrob Chemother, 2017, 72(6):1784-1793.
[14] ABBES S, AMOURI I, TRABELSI H, et al. Analysis of virulence factors and in vivo biofilm-forming capacity of Yarrowia lipolytica isolated from patients with fungemia[J]. Med Mycol, 2017, 55(2):193-202.
[15] LIU W C, CHAN M C, LIN T Y, et al. Candida lipolytica candidemia as a rare infectious complication of acute pancreatitis:a case report and literature review[J]. J Microbiol Immunol Infect, 2013, 46(5):393-396.
[16] BOYD A S, WHELESS L, BRADY B G, et al. Cutaneous Yarrowia lipolytica infection in an immunocompetent woman[J]. JAAD Case Rep, 2017, 3(3):219-221.
[17] D'ANTONIO D, ROMANO F, PONTIERI E, et al. Catheter-related candidemia caused by Candida lipolytica in a patient receiving allogeneic bone marrow transplantation[J]. J Clin Microbiol, 2002, 40(4):1381-1386.
[18] 邹莉. 首次发现解脂耶氏酵母菌败血症[J]. 医学信息, 2015, 28(8):247-247.
[19] NITZULESCU V, NICULESCU M. 3 cases of ocular candidiasis caused by Candida lipolytica [J]. Arch Roum Pathol Exp Microbiol, 1976, 35(3):269-272.
[20] 张冬萍,孙薇. 解脂假丝酵母菌脓毒血症1例实验室检测[J]. 新疆医学, 2018, 48(9):1027-1028.
[21] LAI C C, LEE M R, HSIAO C H, et al. Infections caused by Candida lipolytica[J]. J Infect, 2012, 65(4):372-374.
[22] OZDEMIR H, KARBUZ A, CIFTCI E, et al. Successful treatment of central venous catheter infection due to Candida lipolytica by caspofungin-lock therapy[J]. Mycoses, 2011, 54(5):e647-e649.
[23] MAZUMDER S, TODD W, CLEVELAND K. Fatal Yarrowia lipolytica intra-abdominal abscess with persistent fungemia in a liver transplant recipient[J]. Infect Dis Clin Pract, 2015, 23(5):273-275.
[24] KANG K, YOON H, JUNG S, et al. A case of Yarrowia lipolytica fungemia after raw beef ingestion[J]. Korean J Med, 2008, 74(5):566-569.
[25] YE Q, XU X, LI J, et al. Fungemia caused by Yarrowia lipolytica in a patient with acute lymphoblastic leukemia[J]. J Pediatr Hematol Oncol, 2011, 33(3):e120-e121.
[26] 郑岳臣, 曾敬思, 李家文, 等. 国内首例解脂念珠菌肉芽肿[J]. 临床皮肤科杂志, 2009, 38(1):9-11.
[27] SHIN J H, KOOK H, SHIN D H, et al. Nosocomial cluster of Candida lipolytica fungemia in pediatric patients[J]. Eur J Clin Microbiol Infect Dis, 2000, 19(5):344-349.
[28] CHI H Y, SU Y S, CHEN F L, et al. Breakthrough fungemia caused by Yarrowia lipolytica in a patient with gastric adenocarcinoma during echinocandin therapy[J]. J Infect, 2021, 82(1):e52-e53.
[29] KANTARCIOGLU A S, YUCEL A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains[J]. Mycoses, 2002, 45(5-6):160-165.
[30] FOTEDAR R, AL-HEDAITHY S S. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis[J]. Mycoses, 2005, 48(1):62-67.
[31] STEHR F, KRETSCHMAR M, KROGER C, et al. Microbial lipases as virulence factors[J]. J Mol Catal B Enzym, 2003, 22(5-6):347-355.
[32] RAMESH N, PRIYADHARSINI M, SUMATHI C S, et al. Virulence factors and anti fungal sensitivity pattern of Candida sp. isolated from HIV and TB patients[J]. Indian J Microbiol, 2011, 51(3):273-278.
[33] MONOD M, CAPOCCIA S, LECHENNE B, et al. Secreted proteases from pathogenic fungi[J]. Int J Med Microbiol, 2002, 292(5-6):405-419.
[34] BANKAR A, ZINJARDE S, SHINDE M, et al. Heavy metal tolerance in marine strains of Yarrowia lipolytica[J]. Extremophiles, 2018, 22(4):617-628.
[35] SHU T, HE X Y, CHEN J W, et al. The pH-responsive transcription factors ylrim101 and mhy1 regulate alkaline ph-induced filamentation in the dimorphic yeast Yarrowia lipolytica[J]. mSphere, 2021, 6(3):e00179-21.
[36] WITCHLEY J N, PENUMETCHA P, ABON N V, et al. Candida albicans morphogenesis programs control the balance between gut commensalism and invasive infection[J]. Cell Host Microbe, 2019, 25(3):432-443.e6.
[37] SZABO R. Cla4 protein kinase is essential for filament formation and invasive growth of Yarrowia lipolytica[J]. Mol Genet Genomics, 2001, 265(1):172-179.
[38] SOONG Y V, LIU N, YOON S, et al. Cellular and metabolic engineering of oleaginous yeast Yarrowia lipolytica for bioconversion of hydrophobic substrates into high-value products[J]. Eng Life Sci, 2019, 19(6):423-443.
[39] ZARAGOZA O, MESA-ARANGO A C, GOMEZ-LOPEZ A, et al. Process analysis of variables for standardization of antifungal susceptibility testing of nonfermentative yeasts[J]. Antimicrob Agents Chemother, 2011, 55(4):1563-1570.
[40] STAVROU A A, PEREZ-HANSEN A, LACKNER M, et al. Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts[J]. Med Mycol, 2020, 58(7):987-995.
[41] ARENDRUP M C, BOEKHOUT T, AKOVA M, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections[J]. Clin Microbiol Infect, 2014, 20(Suppl 3):76-98.
[42] COLOMBO A L, JÚNIOR J N D A, GUINEA J. Emerging multidrug-resistant Candida species[J]. Current opinion in infectious diseases, 2017, 30(6):528-538.
[43] PAPPAS P G, KAUFFMAN C A, ANDES D R, et al. Clinical Practice Guideline for the Management of Candidiasis:2016 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis,2016, 62(4):e1-50.
[44] CHEN S C A, PERFECT J, COLOMBO A L, et al. Global guideline for the diagnosis and management of rare yeast infections:an initiative of the ECMM in cooperation with ISHAM and ASM[J]. Lancet Infect Dis, 2021, 21(12):e375-e86.
[45] CHANG C L, PARK T H, LEE E Y, et al. Recurrent self-limited fungemia caused by Yarrowia lipolytica in a patient with acute myelogenous leukemia[J]. J Clin Microbiol, 2001, 39(3):1200-1201.
[46] AGARWAL S, THAKUR K, KANGA A, et al. Catheter-related candidemia caused by Candida lipolytica in a child with tubercular meningitis[J]. Indian J Pathol Microbiol, 2008, 51(2):298-300.